AKT1 and head and neck squamous cell carcinoma: On the other hand, nearly 70% of HNSCC samples have no known genetic mutations directly affecting the core components of the PI3K/AKT pathway [15], suggesting that there are indirect mechanisms contributing to the activation of this pathway.